Craft

Dexcom

Stock Price

$117.9

2024-02-20

Market Capitalization

$45.4 B

2024-02-20

Revenue

$3.6 B

FY, 2023

Dexcom Summary

Company Summary

Overview
Dexcom is a company that specializes in the design, development, and commercialization of continuous glucose monitoring (CGM) systems for people with diabetes. It also offers an integrated suite of apps for diabetes management, that provides insights, alarms and alerts, finger stick elimination, and other solutions.
Type
Public
Status
Active
Founded
1999
HQ
San Diego, CA, US | view all locations
Website
https://www.dexcom.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Kevin Sayer

    Kevin Sayer, Chairman, President and Chief Executive Officer

  • Sadie Stern

    Sadie Stern, EVP, Chief Human Resources Officer

  • Jereme Sylvain

    Jereme Sylvain, EVP, Chief Financial Officer

  • Michael Brown

    Michael Brown, EVP, Chief Legal Officer

Operating MetricsView all

Facilities Leased (US), square feet

1.3M
5.1%

FY, 2021

Controlled Environment Rooms Space, sq. ft.

85.2K
16.1%

FY, 2022

Remaining Performance Obligations (One Year or More)

$20.7M
13.1%

Q1, 2023

LocationsView all

6 locations detected

  • San Diego, CA HQ

    United States

    6340 Sequence Dr

  • Brunn am Gebirge, Niederösterreich

    Austria

    Leopold-Gattringer-Straße 25

  • Burnaby, BC

    Canada

    4445 Lougheed Hwy. #501

  • Mainz, RP

    Germany

    Haifa-Allee 2

  • Horw, LU

    Switzerland

    Allmendstr. 18

  • Camberley, England

    United Kingdom

    Watchmoor Park, Riverside Way

Dexcom Financials

Summary Financials

Revenue (FY, 2023)
$3.6B
Gross profit (FY, 2023)
$2.3B
Net income (FY, 2023)
$541.5M
Cash (FY, 2023)
$566.3M
EBIT (FY, 2023)
$597.7M
Enterprise value
$44.9B

Footer menu